## 5 Results
### Impact of Usage of Distance Spectacles/Contact Lenses  
We did not find any statistically significant differences between the rest-frame conditions for the VRISE scores of participants who successfully completed the experiment. \begin{table}
\begin{tabular}{c c c c c c c} \hline \hline
**VRISE Scale** & **Condition** & **N** & **Mean** & **SD** & **Min Value** & **Max Value** \\ \hline SSQ Total & LA\_NORF & 17 & 23.76 & 19.88 & 0.00 & 63.58 \\  & LA\_RFG & 17 & 24.42 & 18.94 & 3.74 & 71.06 \\  & LA\_RFH & 17 & 31.90 & 27.77 & 0.00 & 93.50 \\  & HA\_NORF & 17 & 34.76 & 33.58 & 0.00 & 112.20 \\  & HA\_RFG & 17 & 32.12 & 23.62 & 3.74 & 78.54 \\  & HA\_RFH & 17 & 27.28 & 23.42 & 0.00 & 67.32 \\ \hline SSQ & LA\_NORF & 17 & 23.75 & 24.98 & 0.00 & 83.52 \\ Disorientation & LA\_RFG & 17 & 30.30 & 32.36 & 0.00 & 111.36 \\  & LA\_RFH & 17 & 33.57 & 30.36 & 0.00 & 97.44 \\  & HA\_NORF & 17 & 42.57 & 39.21 & 0.00 & 125.28 \\  & HA\_RFG & 17 & 31.93 & 28.60 & 0.00 & 83.52 \\  & HA\_RFH & 17 & 30.30 & 27.06 & 0.00 & 83.52 \\ \hline SSQ Nausea & LA\_NORF & 17 & 27.49 & 26.96 & 0.00 & 95.40 \\  & LA\_RFG & 17 & 23.57 & 19.99 & 0.00 & 57.24 \\  & LA\_RFH & 17 & 35.35 & 34.52 & 0.00 & 104.94 \\  & HA\_NORF & 17 & 36.48 & 40.93 & 0.00 & 124.02 \\  & HA\_RFG & 17 & 37.60 & 33.30 & 0.00 & 114.48 \\  & HA\_RFH & 17 & 31.99 & 34.55 & 0.00 & 95.40 \\ \hline SSQ & LA\_NORF & 17 & 13.38 & 12.72 & 0.00 & 45.48 \\ Oculomotor & LA\_RFG & 17 & 14.27 & 11.33 & 7.58 & 53.06 \\  & LA\_RFH & 17 & 18.28 & 16.31 & 0.00 & 53.06 \\  & HA\_NORF & 17 & 18.28 & 18.58 & 0.00 & 68.22 \\  & HA\_RFG & 17 & 17.84 & 11.97 & 0.00 & 37.90 \\  & HA\_RFH & 17 & 13.38 & 12.14 & 0.00 & 37.90 \\ \hline \hline \end{tabular}
\end{table} 
Table 13: Subjective VRISE levels assessed by the SSQ, FMS, and VRNQ (VRISE Section) Questionnaire for the participants experienced with VR Technology. \begin{table}
\begin{tabular}{c c c c} \hline \hline
**VRISE Scale** & **Condition** & **Z** & \(\boldsymbol{p}\) \\ \hline SSQ Total & LA\_NORF–LA\_RFG & \(-0.542\) & 0.306 \\  & LA\_NORF–LA\_RFH & \(-1.452\) & 0.079 \\  & HA\_NORF–HA\_RFG & \(-0.535\) & 0.307 \\  & HA\_NORF–HA\_RFH & \(-1.140\) & 0.136 \\ \hline SSQ & LA\_NORF–LA\_RFG & \(-1.184\) & 0.126 \\ Disorientation & LA\_NORF–LA\_RFH & \(-1.273\) & 0.112 \\  & **HA\_NORF–HA\_RFG** & \(-1.796\) & **0.035 \({}^{*}\)** \\  & HA\_NORF–HA\_RFH & \(-1.704\) & 0.055 \\ \hline SSQ Nausea & LA\_NORF–LA\_RFG & \(-4.222\) & 0.375 \\  & LA\_NORF–LA\_RFH & \(-1.393\) & 0.090 \\  & HA\_NORF–HA\_RFG & \(-0.095\) & 0.471 \\  & HA\_NORF–HA\_RFH & \(-0.807\) & 0.240 \\ \hline SSQ & LA\_NORF–LA\_RFG & \(-0.486\) & 0.396 \\ Oculomotor & LA\_NORF–LA\_RFH & \(-1.393\) & 0.106 \\  & HA\_NORF–HA\_RFG & \(-0.295\) & 0.416 \\  & HA\_NORF–HA\_RFH & \(-1.327\) & 0.099 \\ \hline \hline \end{tabular} \({}^{*}\) and bold \(=p<0.05\) (1-tailed significance).  
\end{table} 
Table 14: Wilcoxon signed-rank test for the SSQ scores between the no rest-frame and rest-frames conditions for users experienced with VR technology. Therefore, we analyzed if there were differences between wearers and non-wearers of distance spectacles. The detailed VRISE results assessed by the SSQ, FMS, and VRNQ questionnaire for all conditions are shown in Tables 15 and 16 for both groups.